Block listing Interim Review

Name of applicant:

Hikma Pharmaceuticals PLC

Name of schemes:

Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")

Period of return

From:

1 April 2025

To:

30 September 2025

Balance of unallotted securities under scheme(s) from previous return:

311,430 Ordinary Shares of 10 pence

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0 Ordinary Shares of 10 pence

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0 Ordinary Shares of 10 pence

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

311,430 Ordinary Shares of 10 pence

Name of contact:

Helen Middlemist

Telephone number of contact:

+44(0)20 7399 2760